OSCR
VENTE TOTALE: 781 422 titres (~23 810 721,90 $ US)
- Insiders
- Schlosser Mario
- Total bought
- —
- Total sold
- $23,810,722
- Last activity
- 2026-09-03
- Last synced
-
2026-09-09 09:58:02
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-09-08
OSCR presents a deeply concerning profile: weak financial health (liquidity score 40, fundamentals trend 35) combined with a negligible catalyst score (25) and no actionable event-driven trigger.
The first sentence of the analysis written for OSCR on 2026-09-08 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 14.4% | 20.1% | 20.8% | 100.0% | 100.0% | |
| Ebit Margin | -3.6% | 0.6% | -4.1% | -14.2% | -29.5% | |
| Ebitda Margin | -3.3% | 1.0% | -3.6% | -13.9% | -28.7% | |
| Operating Profit Margin | -3.4% | 0.6% | -4.0% | -14.8% | -29.7% | |
| Pretax Profit Margin | -3.7% | 0.4% | -4.6% | -14.8% | -29.7% | |
| Continuous Operations Profit Margin | -3.8% | 0.3% | -4.6% | -14.8% | -29.7% | |
| Net Profit Margin | -3.8% | 0.3% | -4.6% | -14.7% | -29.8% | |
| Bottom Line Profit Margin | -3.8% | 0.3% | -4.6% | -14.7% | -29.8% | |
| Current Ratio | 0.949 | 0.897 | -11.819 | 1.397 | 1.708 | |
| Quick Ratio | 0.949 | 0.897 | -11.819 | 1.397 | 1.708 | |
| Solvency Ratio | -0.078 | 0.015 | -0.086 | -0.163 | -0.289 | |
| Cash Ratio | 0.571 | 0.482 | -10.671 | 0.525 | 0.683 | |
| Price To Earnings Ratio | -8.503 | 122.182 | -7.500 | -0.863 | -2.461 | |
| Price To Earnings Growth Ratio | 0.005 | -1.121 | 0.131 | 0.081 | -0.028 | |
| Forward Price To Earnings Growth Ratio | 0.005 | -1.121 | 0.131 | 0.081 | -0.028 | |
| Price To Earnings Diluted Ratio | -8.503 | 140.439 | -7.500 | -0.863 | -2.461 | |
| Price To Earnings Diluted Growth Ratio | 0.005 | -1.302 | 0.131 | 0.081 | -0.028 | |
| Price To Book Ratio | 3.857 | 3.187 | 2.523 | 0.587 | 1.013 | |
| Price To Sales Ratio | 0.322 | 0.352 | 0.346 | 0.127 | 0.731 | |
| Price To Free Cash Flow Ratio | 3.562 | 3.400 | -6.812 | 1.488 | -6.766 | |
| Price To Operating Cash Flow Ratio | 3.444 | 3.303 | -7.452 | 1.374 | -7.730 | |
| Debt To Assets Ratio | 0.068 | 0.062 | 0.083 | 0.066 | 0.000 | |
| Debt To Equity Ratio | 0.440 | 0.296 | 0.372 | 0.335 | 0.000 | |
| Debt To Capital Ratio | 0.306 | 0.228 | 0.271 | 0.251 | 0.000 | |
| Long Term Debt To Capital Ratio | 0.306 | 0.228 | 0.271 | 0.251 | 0.000 | |
| Financial Leverage Ratio | 6.470 | 4.776 | 4.480 | 5.084 | 2.394 | |
| Working Capital Turnover Ratio | -40.651 | 9.558 | 3.425 | 3.555 | 3.356 | |
| Operating Cash Flow Ratio | 0.225 | 0.308 | 1.553 | 0.128 | -0.112 | |
| Operating Cash Flow Sales Ratio | 0.094 | 0.107 | -0.046 | 0.092 | -0.095 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.967 | 0.971 | 1.094 | 0.924 | 1.142 | |
| Debt Service Coverage Ratio | -22.536 | 3.455 | -8.751 | -25.268 | -116.971 | |
| Interest Coverage Ratio | -22.519 | 2.413 | -9.577 | -26.967 | -120.886 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 2.546 | 3.265 | -0.911 | 1.276 | 0.000 | |
| Capital Expenditure Coverage Ratio | 30.102 | 35.064 | -10.641 | 13.110 | -7.021 | |
| Dividend Paid And Capex Coverage Ratio | 30.102 | 35.064 | -10.641 | 13.110 | -7.021 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -3.648 | 22.431 | -2.154 | 1.290 | -0.546 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 14.4% | ▼-5.7% | ▼-36.7% |
| Ebit Margin | -3.6% | ▼-4.2% | ▲6.6% |
| Ebitda Margin | -3.3% | ▼-4.3% | ▲6.4% |
| Operating Profit Margin | -3.4% | ▼-4.0% | ▲6.9% |
| Pretax Profit Margin | -3.7% | ▼-4.1% | ▲6.8% |
| Continuous Operations Profit Margin | -3.8% | ▼-4.1% | ▲6.7% |
| Net Profit Margin | -3.8% | ▼-4.1% | ▲6.7% |
| Bottom Line Profit Margin | -3.8% | ▼-4.1% | ▲6.7% |
| Current Ratio | 0.949 | ▲0.052 | ▲2.322 |
| Quick Ratio | 0.949 | ▲0.052 | ▲2.322 |
| Solvency Ratio | -0.077 | ▼-0.093 | ▲0.043 |
| Cash Ratio | 0.571 | ▲0.089 | ▲2.253 |
| Price To Earnings Ratio | -8.503 | ▼-130.685 | ▼-29.074 |
| Price To Earnings Growth Ratio | 0.005 | ▲1.126 | ▲0.192 |
| Forward Price To Earnings Growth Ratio | 0.005 | ▲1.126 | ▲0.192 |
| Price To Earnings Diluted Ratio | -8.503 | ▼-148.942 | ▼-32.725 |
| Price To Earnings Diluted Growth Ratio | 0.005 | ▲1.307 | ▲0.227 |
| Price To Book Ratio | 3.857 | ▲0.669 | ▲1.623 |
| Price To Sales Ratio | 0.322 | ▼-0.030 | ▼-0.053 |
| Price To Free Cash Flow Ratio | 3.562 | ▲0.162 | ▲4.588 |
| Price To Operating Cash Flow Ratio | 3.444 | ▲0.141 | ▲4.856 |
| Debt To Assets Ratio | 0.068 | ▲0.006 | ▲0.012 |
| Debt To Equity Ratio | 0.440 | ▲0.144 | ▲0.152 |
| Debt To Capital Ratio | 0.305 | ▲0.077 | ▲0.095 |
| Long Term Debt To Capital Ratio | 0.305 | ▲0.077 | ▲0.095 |
| Financial Leverage Ratio | 6.470 | ▲1.694 | ▲1.829 |
| Working Capital Turnover Ratio | -40.651 | ▼-50.209 | ▼-36.499 |
| Operating Cash Flow Ratio | 0.225 | ▼-0.083 | ▼-0.195 |
| Operating Cash Flow Sales Ratio | 0.094 | ▼-0.013 | ▲0.063 |
| Free Cash Flow Operating Cash Flow Ratio | 0.967 | ▼-0.005 | ▼-0.053 |
| Debt Service Coverage Ratio | -22.536 | ▼-25.991 | ▲11.478 |
| Interest Coverage Ratio | -22.519 | ▼-24.932 | ▲12.988 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | 2.546 | ▼-0.720 | ▲1.310 |
| Capital Expenditure Coverage Ratio | 30.102 | ▼-4.963 | ▲17.979 |
| Dividend Paid And Capex Coverage Ratio | 30.102 | ▼-4.963 | ▲17.979 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -3.648 | ▼-26.078 | ▼-7.122 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $3.77B | $3.23B | $2.03B | $522.7M | $1.40B | |
| Enterprise value | $1.43B | $2.00B | $456.6M | -$737.9M | $300.9M | |
| EV / Sales | 0.12x | 0.22x | 0.08x | -0.18x | 0.16x | |
| EV / Op. cash flow | 1.30x | 2.05x | -1.68x | -1.94x | -1.66x | |
| EV / Free cash flow | 1.35x | 2.11x | -1.53x | -2.10x | -1.45x | |
| EV / EBITDA | -3.65x | 22.43x | -2.15x | 1.29x | -0.55x | |
| Net debt / EBITDA | 5.99x | -13.75x | 7.41x | 2.20x | 2.00x | |
| Current ratio | 0.95x | 0.90x | -11.82x | 1.40x | 1.71x | |
| Income quality | -2.47x | 37.45x | 1.01x | -0.62x | 0.32x | |
| Graham number | — | $3 | — | — | — | |
| Graham net-net | -$4 | -$6 | $1 | $1 | $3 | |
| Tax burden | 101.3% | 76.1% | 101.3% | 99.4% | 100.4% | |
| Interest burden | 104.2% | 58.5% | 110.1% | 103.9% | 100.8% | |
| Working capital | -$249.2M | -$326.5M | $2.25B | $1.18B | $1.14B | |
| Invested capital | -$160.8M | -$259.7M | $2.31B | $1.24B | $1.19B | |
| Return on assets | -7.0% | 0.5% | -7.5% | -13.4% | -17.2% | |
| Operating ROA | -7.1% | 1.4% | -5.8% | -15.5% | -20.4% | |
| Return on tangible assets | -7.0% | 0.5% | -7.5% | -13.4% | -17.2% | |
| Return on equity | -45.3% | 2.5% | -33.7% | -68.1% | -41.3% | |
| Return on invested capital | -27.1% | 2.7% | -6.2% | -39.1% | -33.6% | |
| Return on capital employed | -27.1% | 3.4% | -6.2% | -39.1% | -33.5% | |
| Earnings yield | -11.8% | 0.8% | -13.3% | -116.0% | -40.8% | |
| Free cash flow yield | 28.1% | 29.4% | -14.7% | 67.2% | -14.8% | |
| Capex / Op. cash flow | 3.3% | 2.9% | -9.4% | 7.6% | -14.2% | |
| Capex / Depreciation | 125.9% | 86.8% | 83.3% | 189.8% | 177.2% | |
| Capex / Sales | 0.3% | 0.3% | 0.4% | 0.7% | 1.3% | |
| SG&A / Sales | 17.5% | 0.0% | 0.0% | 34.4% | 13.8% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.7% | 1.2% | 2.7% | 2.7% | 4.5% | |
| Intangibles / Total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Days sales outstanding | 14d | 13d | 31d | 103d | 198d | |
| Days payables outstanding | -4d | 70d | 81d | 0d | 0d | |
| Operating cycle | 14d | 13d | 31d | 103d | 198d | |
| Cash conversion cycle | 17d | -57d | -50d | 103d | 198d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+16.7%EV / Sales ▼-44.1%EV / EBITDA ▼-116.3%EV / Op. cash flow ▼-0.745Earnings yield ▼-0.125
Profitability
Return on equity ▼-0.478Return on assets ▼-0.075Return on invested capital ▼-0.298Return on capital employed ▼-0.305Operating ROA ▼-0.085Income quality ▼-39.921Tax burden ▲+0.253
Efficiency
Days sales outstanding ▲+1.244Days payables outstanding ▼-73.227Operating cycle ▲+1.244Cash conversion cycle ▲+74.471Capex / Sales +0.000R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.052Net debt / EBITDA ▲+19.741Working capital ▲+77340000.000Invested capital ▲+98897000.000Intangibles / Total assets n/a
Change over 5 years
Valuation
Market cap ▲+168.4%EV / Sales ▼-22.2%EV / EBITDA ▼-568.3%EV / Op. cash flow ▲+2.958Earnings yield ▲+0.290
Profitability
Return on equity ▼-0.041Return on assets ▲+0.102Return on invested capital ▲+0.065Return on capital employed ▲+0.064Operating ROA ▲+0.133Income quality ▼-2.790Tax burden ▲+0.010
Efficiency
Days sales outstanding ▼-184.382Days payables outstanding n/aOperating cycle ▼-184.382Cash conversion cycle ▼-180.748Capex / Sales ▼-0.010R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.759Net debt / EBITDA ▲+3.992Working capital ▼-1393901000.000Invested capital ▼-1352162000.000Intangibles / Total assets n/a
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-09-04 Oscar Health, Inc. (OSCR) Just Overtook the 20-Day Moving Average After reaching an important support level, Oscar Health, Inc. (OSCR) could be a good stock pick from a technical perspective. OSCR surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
- 2026-09-04 Oscar Health, Inc. (OSCR) Just Overtook the 50-Day Moving Average Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, OSCR broke out above the 50-day moving average, suggesting a short-term bullish trend.
- 2026-09-04 Best Growth Stocks to Buy for September 4th BMA, ATI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 4, 2026.
- 2026-09-02 Oscar Health Membership Surges but Profitability Remains Key Oscar Health''s membership jumps 46% to 2.96 million, but seasonal enrollment and medical utilization keep profitability in focus.
- 2026-09-02 Best Momentum Stocks to Buy for September 2nd OSCR, LQDT and GEO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 2, 2026.
- 2026-09-02 New Strong Buy Stocks for September 2nd LCUT, CURI, OSCR, CTOS and CHYM have been added to the Zacks Rank #1 (Strong Buy) List on September 2, 2026.
- 2026-09-01 Oscar Health Skyrockets 109% YTD: Time to Bet on the Stock Now? Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.
- 2026-08-28 Best Growth Stocks to Buy for August 28th SNDR, NESR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 28th, 2026.
- 2026-08-26 Best Growth Stocks to Buy for August 26th SNDR, NESR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 26th, 2026.
- 2026-08-24 As Health Insurers Gain Handle On Costs, Stocks Are Soaring Again Following a parade of health insurance company earnings reports this summer, stocks are rising and costs appear to be under control for now.